来宝网移动站

Quanta BioDesign, Ltd广泛参与药物研发和诊断开发的公司产品的生产和销售。 公司始建于1997年，属于保罗·戴维斯博士名下BioOrganic Technologies, LLC，1999年的春天为了更好地反映公司的使命，更名为Quanta BioDesign, Ltd。 公司所有的产品都是基于一种特有的叫离散聚乙二醇（dPEG®）的化学物质。 我们的单一分子量乙二醇共轭技术®dPEG，使诊断和治疗产品安全高价格低，解决如聚集和非特异性相互作用，水溶性差，血清半衰期寿命短，毒性和免疫原性，出货不畅等发展中常见的问题。 公司的dPEG®产品线，可以量身定制，为了广泛的诊断和治疗中的应用，以满足特定的物理，化学和形态的要求。 Quanta BioDesign制定新的交联和标记化学品纳入dPEG®技术，为了新的方法，治疗和诊断的发展等到了大量资金支持。

Quanta BioDesign, Ltd. was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs.  The company was founded in 1997 by Paul D. Davis, Ph.D. under the name BioOrganic Technologies, LLC.  In the spring of 1999 the name was changed to Quanta BioDesign, Ltd., to better reflect the company’s mission.  All of our products are based on our proprietary discrete polyethylene glycol (dPEG®) chemistries, including our processes for making these compounds. Our single molecular weight ethylene glycol conjugation technology, dPEG®, can eliminate common problems found in the development of diagnostic and therapeutic products, such as aggregation and non-specific interactions, poor water solubility, poor delivery, delivery issues/options, short serum half-life, toxicity and antigenicity.  The dPEG® product line can be custom tailored to meet specific physical, chemical and morphological requirements in a broad array of diagnostic and therapeutic applications.  Quanta BioDesign is involved in developing new cross-linking and labeling chemistries that incorporate the dPEG® technology, and will allow for new approaches in the area of therapeutic and diagnostic development.

上海柒赛科技有限公司为客户提供相关产品
www.7sci.com
Tel：021-68409203
Fax: 021-68409203
MP:18502187648
QQ:2263582710
Email:info@7sci.com